Clinical Trials Logo
  1. Home
  2. Arthritis, Juvenile Rheumatoid
  3. NCT01412021

Special Investigation (All Case Survey) in Patients With Juvenile Idiopathic Arthritis

Arthritis, Juvenile Rheumatoid Clinical Trial

Official title:
Humira® for Subcutaneous Injection Special Investigation ( All-case Survey ) in Patients With Juvenile Idiopathic Arthritis Study

Clinical Trial Summary

This study of Humira will be conducted to clarify the following with regard to the treatment of juvenile idiopathic arthritis affecting multiple joints with this drug:

- Unknown adverse drug reactions (especially important adverse drug reactions)

- Incidence and conditions of occurrence of adverse reactions in the clinical setting

- Factors that may affect the safety and effectiveness of Humira

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01412021
Study type Observational
Source AbbVie
Contact
Status Completed
Phase
Start date July 1, 2011
Completion date April 2, 2018
View Details
See also
  Status Clinical Trial Phase
Completed NCT00807846 - A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects Phase 4
Completed NCT00279747 - A One Year Double-blind Trial to Investigate the Efficacy and Safety of Meloxicam Oral Suspension in Juvenile Rheumatoid Arthritis (JRA/JIA) Phase 3
Completed NCT00652925 - A Study to Evaluate the Efficacy and Safety of Celecoxib Suspension Compared to Naproxen Suspension in Patients With JRA Phase 3
Completed NCT02001844 - Foot Orthoses (FOs) on Pain, Quality of Life and the Gait With Children Diagnosed With JIA N/A
Completed NCT00731965 - Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Juvenile Idiopathic Arthritis Phase 4
Completed NCT02067962 - Identification of Genes Involved in Juvenile Idiopathic Arthritis by Wholel Exome Sequencing N/A
Terminated NCT00868751 - Single Patient Use of Tocilizumab in Systemic Onset Juvenile Idiopathic Arthritis N/A
Terminated NCT00637780 - Study To Determine The Pharmacokinetics Of Sulfasalazine In Children With Juvenile Idiopathic Arthritis Phase 4
Completed NCT00001614 - The Safety and Efficacy of Chicken Type II Collagen on Uveitis Associated With Juvenile Rheumatoid Arthritis Phase 1
Enrolling by invitation NCT02377245 - Juvenile Inflammatory Rheumatism (JIR) Cohorte
Completed NCT00426218 - Safety, Efficacy and Pharmacokinetics of Subcutaneous ACZ885 in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA) Phase 1/Phase 2
Completed NCT00034853 - Meloxicam [Mobic] in Juvenile Rheumatoid Arthritis (JRA) Phase 3
Recruiting NCT06000566 - Drug Compliance and Affecting Factors in Juvenile Idiopathic Arthritis
Terminated NCT00511329 - Growth Hormone in Children With Juvenile Rheumatoid Arthritis (JRA) and With Crohn's Disease Phase 2/Phase 3
Terminated NCT00688545 - Naturalistic Safety Registry Of Celecoxib (CELEBREX(R)) And NSAIDs In Juvenile Idiopathic Arthritis
Recruiting NCT00012506 - The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on Uveitis Associated With Juvenile Rheumatoid Arthritis Phase 3